Skip to content

Comparison of Ambu Auragain and I-Gel Supraglottic Airways in Adult Patients at an Ambulatory Surgery Center

Comparison of Ambu Auragain and I-Gel Supraglottic Airways in Adult Patients at an Ambulatory Surgery Center

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04286581
Enrollment
148
Registered
2020-02-27
Start date
2021-03-22
Completion date
2021-10-31
Last updated
2022-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Surgery

Brief summary

The purpose of this study is to determine if an I-gel laryngeal mask airway (LMA) has a higher oropharyngeal leak pressure compared to an Ambu Auragain in adult patients in an ambulatory surgery center.

Detailed description

Patients who are scheduled for elective ambulatory surgery under general anesthesia will be randomized to one of two groups. Group 1 will receive an I-gel laryngeal mask airway (LMA) and group 2 will receive an Ambu Auragain LMA.

Interventions

DEVICEI-Gel Laryngeal Mask Airway

The I-Gel Laryngeal Mask Airway is a medical device that keeps a patient's airway open during anaesthesia or unconsciousness.

DEVICEAmbu Auragain Laryngeal Mask Airway

The Ambu Auragain Laryngeal Mask Airway is a medical device that keeps a patient's airway open during anaesthesia or unconsciousness.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Intervention model description

Patients who are scheduled for elective ambulatory surgery under general anesthesia will be randomized to one of two groups. Group 1 will receive an I-gel laryngeal mask airway (LMA) and group 2 will receive an Ambu Auragain LMA.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

\- undergoing outpatient ambulatory surgery under general anesthesia that is amenable to using a laryngeal mask airway

Exclusion criteria

* non-English speaking patients * patients with abnormal airway anatomy

Design outcomes

Primary

MeasureTime frameDescription
Oropharyngeal Leak Pressure (OLP)immediately after placementOLP will be measured immediately after insertion. This will be accomplished by closing the expiratory valve while keeping fresh gas flow at 3 liters/minute until equilibrium is reached. Pressure will be reported in cmH2O.

Secondary

MeasureTime frameDescription
Time to Placementtime from opening mouth to successful placement (4 hours)Time required to place laryngeal mask airway will be measured and reported in seconds.
Sore ThroatPain right before discharge from pacu (8 hours)Participants will be asked upon discharge from recovery room (approximately 8 hours post surgery) to rate the soreness of their throat on a numerical rating scale of 0-10 (0 being no soreness and 10 being maximum imaginable soreness). Participants will be asked to rate throat soreness again via phone call approximately 24 hours after surgery.

Countries

United States

Participant flow

Participants by arm

ArmCount
Igel Larnygeal Mask Airway
Group 1 will receive the I-Gel Laryngeal Mask Airway for airway maintenance during general anesthesia I-Gel Laryngeal Mask Airway: The I-Gel Laryngeal Mask Airway is a medical device that keeps a patient's airway open during anaesthesia or unconsciousness.
70
Ambu Auragain Laryngeal Mask Airway
Group 2 will receive the Ambu Auragain Laryngeal Mask Airway for airway maintenance during general anesthesia Ambu Auragain Laryngeal Mask Airway: The Ambu Auragain Laryngeal Mask Airway is a medical device that keeps a patient's airway open during anaesthesia or unconsciousness.
70
Total140

Baseline characteristics

CharacteristicIgel Larnygeal Mask AirwayAmbu Auragain Laryngeal Mask AirwayTotal
Age, Continuous45 years
STANDARD_DEVIATION 16.9
44.6 years
STANDARD_DEVIATION 19
44.8 years
STANDARD_DEVIATION 17.9
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
27 Participants34 Participants61 Participants
Sex: Female, Male
Male
43 Participants36 Participants79 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Oropharyngeal Leak Pressure (OLP)

OLP will be measured immediately after insertion. This will be accomplished by closing the expiratory valve while keeping fresh gas flow at 3 liters/minute until equilibrium is reached. Pressure will be reported in cmH2O.

Time frame: immediately after placement

ArmMeasureValue (MEAN)Dispersion
Igel Larnygeal Mask AirwayOropharyngeal Leak Pressure (OLP)20.9 cm H20Standard Deviation 6
Ambu Auragain Laryngeal Mask AirwayOropharyngeal Leak Pressure (OLP)22.6 cm H20Standard Deviation 5.5
Secondary

Sore Throat

Participants will be asked upon discharge from recovery room (approximately 8 hours post surgery) to rate the soreness of their throat on a numerical rating scale of 0-10 (0 being no soreness and 10 being maximum imaginable soreness). Participants will be asked to rate throat soreness again via phone call approximately 24 hours after surgery.

Time frame: Pain right before discharge from pacu (8 hours)

ArmMeasureValue (MEDIAN)
Igel Larnygeal Mask AirwaySore Throat0 numerical rating scale
Ambu Auragain Laryngeal Mask AirwaySore Throat0 numerical rating scale
Secondary

Sore Throat

Participants will be asked upon discharge from recovery room (approximately 8 hours post surgery) to rate the soreness of their throat on a numerical rating scale of 0-10 (0 being no soreness and 10 being maximum imaginable soreness). Participants will be asked to rate throat soreness again via phone call approximately 24 hours after surgery.

Time frame: 24 hours post-surgery

ArmMeasureValue (MEDIAN)
Igel Larnygeal Mask AirwaySore Throat0 numerical rating scale
Ambu Auragain Laryngeal Mask AirwaySore Throat0 numerical rating scale
Secondary

Time to Placement

Time required to place laryngeal mask airway will be measured and reported in seconds.

Time frame: time from opening mouth to successful placement (4 hours)

ArmMeasureValue (MEDIAN)
Igel Larnygeal Mask AirwayTime to Placement8.9 seconds
Ambu Auragain Laryngeal Mask AirwayTime to Placement30.4 seconds

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026